VYVANSE

Identification of Vyvanse

Please sign up for a free trial to see the description of this product.

Examples of the descriptions of OTHER drugs:

Lipitor 10 mg

Apo-Irbesartan 150 mg

Crestor 20 mg

Google image searchProduct monograph

Active ingredient

lisdexamfetamine dimesylate, 30 MG

DIN: 02322951

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Schedule G (CDSA I)

Company: TAKEDA CANADA INC

Date: 19-APR-2021

ATC:

N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
N06B — PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, ATC/DDD)
N06BA — Centrally acting sympathomimetics (ATC, ATC/DDD)
N06BA12 — LISDEXAMFETAMINE (ATC/DDD)

Reference brand drug: Vyvanse

External Links for Vyvanse

Search on Google

Vyvanse side effects
Vyvanse dosage
lisdexamfetamine dimesylate side effects
lisdexamfetamine dimesylate dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find vyvanse photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.